Vimarsana
Biggest News Aggregation in the World

Virus Genomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Virus Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Virus Genomics Today - Breaking & Trending Today

A coordinated advance | Laboratory News - Vimarsana News

A coordinated advance | Laboratory News

Deep virology knowledge, urgency and partnership form the crucible for rapid antibody development to combat respiratory virus infection, explains Paul K...

Discovery of Separate Monkeypox Strain Suggests Two Outbreaks Are Happening - Vimarsana News

Discovery of Separate Monkeypox Strain Suggests Two Outbreaks Are Happening

One expert said it's hard to know whether a separate strain has been circulating in travelers for years or whether it's gained an advantage now.

'Cold sore' virus may have gained prominence thanks to Bronze Age smooching - Vimarsana News

'Cold sore' virus may have gained prominence thanks to Bronze Age smooching

The herpes virus behind cold sores may have first spread widely about 5,000 years ago, possibly due to the rising popularity of kissing at the time, researchers say.

RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies - Vimarsana News

RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies

- UK-based RQ Biotechnology Ltd (RQ Bio) launches with funding from licensing deal with AstraZeneca for RQ Bio's existing early stage monoclonal antibodies...

LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2 - Vimarsana News

LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2 - read this article along with other careers information, tips and advice on BioSpace